Japan's Eisai said on Monday its Alzheimer's treatment developed with Biogen , Leqembi, was approved by the country's health ministry, making it the second nation after the United States to clear its use. It can now be used in Japan as a treatment for slowing progression of mild cognitive impairment and mild dementia due to Alzheimer's disease. The drug is the first treatment shown to slow progression of the disease for people in the earlier stages of Alzheimer's.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles